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Abstract: The β-amyloid (Aβ) peptide plays a key role in the pathogenesis of Alzheimer’s disease.
The methionine (Met) residue at position 35 in Aβ C-terminal domain is critical for neurotoxicity,
aggregation, and free radical formation initiated by the peptide. The role of Met in modulating
toxicological properties of Aβmost likely involves an oxidative event at the sulfur atom. We therefore
investigated the one- or two-electron oxidation of the Met residue of Aβ25-35 fragment and the
effect of such oxidation on the behavior of the peptide. Bicarbonate promotes two-electron
oxidations mediated by hydrogen peroxide after generation of peroxymonocarbonate (HCO4−,
PMC). The bicarbonate/carbon dioxide pair stimulates one-electron oxidations mediated by carbonate
radical anion (CO3•−). PMC efficiently oxidizes thioether sulfur of the Met residue to sulfoxide.
Interestingly, such oxidation hampers the tendency of Aβ to aggregate. Conversely, CO3•− causes
the one-electron oxidation of methionine residue to sulfur radical cation (MetS•+). The formation of
this transient reactive intermediate during Aβ oxidation may play an important role in the process
underlying amyloid neurotoxicity and free radical generation.
Keywords: peroxymonocarbonate; carbonate radical anion; β-amyloid; methionine sulfoxide; sulfur
centered radical; reactive sulfur species; sulfur radical cation
1. Introduction
Alzheimer’s disease (AD) is one of the most disabling dementia disorders among the elderly,
characterized by progressive loss of memory and cognitive functions. Neurofibrillary tangles of
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tau protein, neuronal loss, and amyloid plaques are the hallmarks of the disease [1,2]. The major
constituent of the amyloid plaques is a 39–43 amino acid peptide named β-amyloid peptide (Aβ) which,
through conformational modifications, becomes prone to form aggregates—from soluble oligomers or
protofibrils to insoluble large fibrils—and is therefore responsible for various pathological effects [3,4].
Amyloid formation is generally associated with the AD clinical manifestations and there are many
reports of Aβ peptides being toxic to neuronal cells [5–7]. Although the central role of Aβ in the
pathogenesis of the disease is undisputed, the precise mechanism(s) of action and the nature of the
toxic species remain to be identified [8].
The damage caused by oxidative stress may play an important role in the initiation and progression
of AD. It has been shown that the AD brain is subject to increased oxidative stress [9,10] and that
increased Aβ deposits are associated with the sites where neurodegeneration and oxidative stress
coexist [11]. According to this, in the Aβ-associated oxidative stress model of neurodegeneration,
the peptide is directly responsible for free radical-mediated damage to neuronal membrane systems,
leading to subsequent neuronal loss [12–14]. Different studies have suggested that the toxic effects of
Aβ involve its own oxidation and free radical generation, ascribing a critical role to the methionine
(Met) residue at 35 position in the Aβ peptide [14–16]. Met-35 is one of the most susceptible
residues to be oxidized [17], especially under oxidative stress conditions [18] and is essential for
peptide neurotoxicity [19]. In fact, when it is replaced by norleucine or cysteine [19,20] or when it is
sequestered within a lipid environment [21], or when it is lacking, as in Aβ1-28, the peptide loses its
neurotoxic properties.
In the oxidative event that occurs on Met-35 residue, the thioether sulfur can undergo a two- or
one-electron oxidation (Scheme 1). The two-electron oxidation leads to the production of methionine
sulfoxide (MetSO) [22], that could be further reduced to Met for the intervention of MetSO reductase,
an enzyme whose activity is reduced in AD brains [23], or further oxidized to Met sulfone. Instead, the
one-electron oxidation of the thioether sulfur leads to the formation of a positive charged sulfur radical
(MetS•+) [24].
Scheme 1. One- and two-electron oxidations of Aβ25-35 methionine residue on the thioether sulfur.
In order to better elucidate the biochemical process underlying amyloid neurotoxicity and free
radical generation, we investigated the oxidative modifications of Aβ by two oxidants derived from the
main physiological buffer, the bicarbonate/carbon dioxide pair: peroxymonocarbonate, HCO4− (PMC),
that catalyzes a two-electron oxidation, and carbonate radical anion (CO3•−), which is a one-electron
oxidant. The experiments were performed by using Aβ25-35, a fragment of the full length peptide
Aβ1-42, containing 11 amino acids and presenting Met-35 as C-terminal residue, which has been shown
to be more rapidly toxic and to cause more oxidative damage than the native full-length peptide [25].
Regarding the oxidant species, PMC was generated by the reaction of bicarbonate with hydrogen
peroxide [26], while carbonate radical anion was generated by SOD/H2O2 system in the presence
of bicarbonate [27,28]. Products derived from Aβ25-35 oxidation were analyzed by HPLC and mass
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spectrometry and the effects of such oxidation on the aggregation of the peptide were determined by
means of spectrofluorimetry, atomic force microscopy, and dynamic light scattering.
2. Results
2.1. Oxidation of Aβ25-35 Fragment by PMC (HCO4−)
The oxidation of Aβ25-35 fragment by PMC was evaluated by HPLC. The chromatographic
profiles of Aβ25-35 solution were incubated for 120 min with HCO4− evidenced, in addition to the peak
corresponding to the parent Aβ25-35 fragment (Met-Aβ25-35) at 15 min retention time (RT), the formation
of a new peak (MetSO-Aβ25-35) with a RT of 11 min (Figure 1).
Figure 1. HPLC profile of Aβ25-35 incubated for 120 min with peroxymonocarbonate (PMC or HCO4−).
10 µM Aβ25-35 was allowed to react with peroxymonocarbonate at 0.8 mM final concentration in 0.1 M
phosphate buffer, pH 7.4, containing 0.1 mM DTPA. After 120 min at room temperature, aliquots of
incubation mixture were analyzed by HPLC.
Taking into account that the only residue susceptible to be oxidized in the fragment is the Met
located at 35 position [18] and the oxidative reactions mediated by PMC proceed through a bi-electronic
mechanism [22], the production of the Aβ25-35 fragment with the Met residue oxidized to methionine
sulfoxide (MetSO-Aβ25-35) is expected. In order to confirm this, eluted compounds from HPLC analysis
corresponding to the two peaks were collected and analyzed by mass spectrometry. Mass spectra
of the two fractions are shown in Figure 2. The two main molecular ions, at m/z = 1060 and 1076,
correspond respectively to Aβ25-35 and the same peptide with an additional oxygen atom, confirming
the formation of MetSO residue.
The time-dependent conversion of Aβ25-35 to MetSO-Aβ25-35 by the bi-electronic oxidation
was monitored by HPLC analysis. Figure 3 shows the concomitant Met-Aβ25-35 diminution and
MetSO-Aβ25-35 increase.
MetSO-Aβ25-35 formation was also evidenced by HPLC analysis when the peptide was incubated
with hydrogen peroxide. The oxidation ability of hydrogen peroxide was lower than that of PMC. In
fact, an amount of 41% of amyloid was found to be oxidized after 120 min incubation with PMC, while
only 18% was oxidized after the same incubation time with hydrogen peroxide (Figure 4, left).
The sensitiveness to oxidation by HCO4− of the Met residue in the Aβ25-35 peptide was compared
to that of free L-Met in the same experimental conditions. Figure 4 (right) shows that the free amino
acid was oxidized to a higher extent compared to the Met residue of the peptide.
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Figure 2. Mass spectra (m/z) obtained by MALDI-ToF MS analysis related to Aβ25-35 (left) and the
same peptide with the methionine residue oxidized to methionine sulfoxide (right). 1060 and 1076 m/z
correspond to Met-Aβ25-35 and MetSO-Aβ25-35, respectively. The peaks at 1098, 1136, 1114, and 1152 m/z
are related to their +K [M + 39] and +2K [M + 76] m/z adducts.
Figure 3. Time course of Aβ25-35 oxidation by peroxymonocarbonate. To a reaction mixture containing
10 µM Aβ25-35 in 0.1 M phosphate buffer, pH 7.4, and 0.1 mM DTPA, peroxymonocarbonate was added
at 0.8 mM final concentration. At various time intervals of incubation at 37 ◦C, the reaction was stopped
by addition of catalase (400 U/mL) and the reaction products were analyzed by HPLC.
Figure 4. Time course of Aβ25-35 oxidation by peroxymonocarbonate or hydrogen peroxide (left).
Aβ25-35 and L-methionine oxidation by peroxymonocarbonate at 120 min (right). To reaction mixture
containing 10 µM Aβ25-35 or 10 µM L-methionine in 0.1 M phosphate buffer, pH 7.4, and 0.1 mM
DTPA, peroxymonocarbonate was added at 0.8 mM final concentration. Hydrogen peroxide was 5 mM.
At various time intervals of incubation at 37 ◦C, the reaction was stopped by addition of catalase
(400 U/mL) and the reaction products analyzed by HPLC.
Molecules 2020, 25, 961 5 of 17
2.2. Oxidation of Free Methionine and Aβ25-35 by CO3•− (SOD/H2O2/Bicarbonate System)
Oxidative reactions mediated by SOD/H2O2 system in the presence of bicarbonate proceeded
through a mono-electronic mechanism by which the highly reactive carbonate radical anion (CO3•−) is
formed. The effect of HCO3−/CO2 pair on the oxidation of free L-Met in the presence of SOD/H2O2 was
indirectly evaluated quantifying the production of MetSO by HPLC. As shown in Figure 5, free Met
was almost completely consumed after 60 min incubation in the presence of SOD/H2O2/bicarbonate
system. However, only a fraction (about 50%) was transformed in MetSO. It can be rationally assumed
that the remaining part was oxidized by CO3•− through a mono-electronic mechanism to its radical
cation form (MetS•+), and then degraded to volatile sub-products, such as ammonia, carbon dioxide,
and methanthiol, undetectable by HPLC analysis [29–31].
Figure 5. Oxidation of free L-methionine by carbonate radical anion. 10 µM L-methionine was
incubated at 37 ◦C with 31 µM SOD, 25 mM sodium bicarbonate, 0.1 mM DTPA in 0.1 M phosphate
buffer, pH 7.4. Reaction was started by the addition of 1 mM H2O2. At various time intervals, the
reaction was stopped by addition of catalase (400 U/mL) and the reaction products analyzed by HPLC.
On the other hand, in the absence of HCO3−/CO2, the SOD/H2O2 system determined the full
oxidation of L-Met to its sulfoxide. This can be explained by the fact that in these conditions the reaction
of SOD with hydrogen peroxide generates •OH radical that inactivates the enzyme [32]; therefore,
the observed oxidation was due exclusively to a two-electron mechanism mediated by H2O2 excess
(not shown).
When the Aβ25-35 was incubated with the SOD/H2O2/bicarbonate system under the same
experimental conditions, the peak corresponding to the peptide completely disappeared in HPLC
chromatogram, but no new peak appeared.
Therefore, the evaluation of one-electron Aβ25-35 oxidation was indirectly performed by
determining the rate of dihydrorhodamine-123 (DHR) oxidation through mono-electronic mechanism
(Scheme 2).
Scheme 2. Two-step mono-electronic oxidation of dihydrorhodamine-123 (DHR).
In the presence of CO3•−, DHR is oxidized first to DHR• radical, and subsequently another
electron is abstracted to produce fully oxidized rhodamine (R):
DHR + CO3•−→ DHR• + CO32−
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DHR• + CO3•−→ R + CO32−
Interestingly, Aβ25-35 acts as a “scavenger”, competing with DHR in the reaction with carbonate
radical anion generated by the SOD/H2O2/bicarbonate system and showed a much higher ability than
free Met in inhibiting the carbonate radical anion-mediated DHR oxidation (Figure 6). The scavenging
activity of the free amino acid was very low and a 100-fold Met concentration higher than that of
peptide was required to obtain a similar reduction of DHR oxidation rate (not shown).
Figure 6. Effect of Aβ25-35 and L-Met on DHR oxidation mediated by carbonate radical anion. Aβ25-35
or L-methionine (50 µM final concentration) was added to a solution containing 25 µM DHR, 31 µM
SOD, 0.1 mM DTPA, and 25 mM sodium bicarbonate in 0.2 M phosphate buffer, pH 7.4. Reaction
was started by the addition of 1 mM H2O2. Oxidized DHR was quantified spectrophotometrically at
500 nm.
Noteworthily, the ability of the amyloid to protect DHR from oxidation is exclusive for the
non-aggregated peptide. When Aβ25-35 was incubated for longer times in DTPA and phosphate buffer
(aggregation-favoring conditions), it failed to protect DHR from one-electron oxidation by CO3•−.
Rather, the oxidation rate of DHR in the presence of aggregated peptide was even enhanced compared
to the control. Figure 7 shows the kinetics of DHR oxidation in the presence of two different states
of Aβ25-35 aggregation. After 24 h, during which the peptide was allowed to stay in aggregating
conditions, the oxidation rate of DHR was 1.3 fold higher than that of control. The same behavior with
lower radical scavenging effects on reaction kinetics was observed using ABTS as a reagent instead of
DHR by monitoring the formation of ABTS+• radical cation (not shown).
Figure 7. Effect of different aggregation states on the reaction rate of DHR oxidation by CO3•−. Freshly
dissolved Aβ25-35 (blue line) and aggregated Aβ25-35 (red line) after 24 h incubation. Aβ25-35 (50 µM
final concentration) was added to a solution containing 25 µM DHR, 31 µM SOD, 0.1 mM DTPA, and
25 mM sodium bicarbonate in 0.2 M phosphate buffer, pH 7.4. Reaction was started by the addition of
1 mM H2O2. DHR oxidation rate was measured spectrophotometrically at 500 nm.
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2.3. Effect of One-Electron and Two-Electron Oxidation on Aβ25-35 Aggregation
The effect of the two different oxidative modifications of Aβ25-35 exerted by HCO4− or CO3•− on
Aβ25-35 aggregation were investigated by means of spectrofluorimetry (Thioflavin-T assay), dynamic
light scattering (DLS), and atomic force microscopy (AFM).
A major consideration needs to be taken into account while using AFM to assess the structures of
Aβ samples prepared with the drop casting method on mica: although this deposition technique is
quite common and easy to apply, it confers a high heterogeneity to the sample, hampering a quantitative
statistical analysis of the observed structures [33]. However, the high resolution of the technique can
provide, under some circumstances, a clear idea of the sample properties, i.e., it can be clearly observed
whether there are substantial differences among the samples [33]. Figure 8 reports typical images of
the specimens, which clearly present morphological differences. As shown in panel (a) in the blank
sample there are huge amorphous aggregates of several microns in size and many structures in the
order of several hundreds of nanometers that look globular. Panel (b) reports the typical landscape of
the one-electron oxidation sample that appears similar to the previous one in terms of co-presence of
big aggregates and smaller globular structures. In this case, however, the presence of aggregates of
several microns of diameter is reduced and the globular structures ranges from one to some hundreds
of nanometers. From an atomic microscopic point of view, this sample looks similar to the previous
aggregated Aβ25-35 but observed one step before that the huge aggregation process takes place. Finally,
in panel (c) of Figure 8, a representative image of the two-electron oxidation sample is shown. In this
case the topography is dramatically different, the sample appears scattered, and none of the huge
aggregates discussed above have been found, more precisely no structures with diameter of one micron
were found. This sample is mainly constituted of small elongated structure of the nanometer range
in length, that resemble the fibrillary structure of amyloid fibrils maybe at the very first steps of the
aggregation process. It should be noticed that one single fibril per field of view was imaged.
Figure 8. Atomic force microscopy (AFM) typical morphologies of aggregated Aβ25-35 in the presence
or absence of HCO4− (two-electron oxidant) or CO3•− (one-electron oxidant) after 24 h aggregation.
The aggregated amyloid (a) sample present almost everywhere amorphous structures and globular
aggregates of several microns in size. The one-electron reaction (b) sample is similar to the aggregated
one in terms of dimensions of the aggregates but their presence is diminished. Two-electron oxidation
sample (c), instead, present smaller and scattered structures of elongated nature, in this latter sample
very rarely were observed amorphous structures of several hundreds of nanometers in size.
Thioflavin-T (Th-T) assay revealed that after 24 h incubation (Figure 9) the one-electron oxidation
mediated by CO3•− inhibits peptide aggregation for a 10% with respect to the control aggregated
Aβ25-35. On the other hand, the PMC oxidation of thioether sulfur to sulfoxide (HCO4−-mediated
two-electron oxidation) induces less than 40% aggregation compared to the fully aggregated peptide.
The time-dependent aggregation on HCO4− oxidized peptide was also investigated by HPLC.
The aggregated amyloid peptide was indirectly quantified by determining the decrease of soluble
amyloid peptide. As confirmed by HPLC (Figure 10), the amount of aggregated peptide formed in the
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presence of HCO4− was lower compared to that formed in the absence of the oxidant. A decrease of
about 40% was observed after 180 min incubation with PMC.
Figure 9. Thioflavin-T fluorimetric aggregation assay of Aβ25-35 in the presence or absence of HCO4−
(two-electron oxidant) or CO3•− (one-electron oxidant) after 24 h aggregation.
Figure 10. Aβ25-35 aggregation in the presence or absence of peroxymonocarbonate. Reaction mixture
contained 10 µM Aβ25-35 in 0.1 M phosphate buffer, pH 7.4, and 0.1 mM DTPA (squares), when
present, peroxymonocarbonate was added at 0.8 mM final concentration (triangles). After various
time incubation at 37 ◦C, the reaction was stopped by addition of catalase (400 U/mL) and the reaction
products analyzed by HPLC.
The effect on aggregation and on the tendency of the oxidized peptide to aggregate was explored
also by dynamic light scattering experiments. The same samples for AFM and Thioflavin-T analyses
were analyzed by DLS after filtering samples through 0.45 µm pore diameters filters. As shown in
Figure 11, control Aβ25-35 and CO3•−-exposed Aβ25-35 (one-electron oxidation) revealed the presence
of aggregated particles with micron-scale diameter while the two-electron oxidation of Aβ25-35 stops
its tendency to form aggregates, maintaining the smaller nano-scale formed particles.
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Figure 11. Dynamic light scattering (DLS) analyses of Aβ25-35 in the presence or absence of HCO4−
(two-electron oxidant) or CO3•− (one-electron oxidant). Only the sulfoxide formation (red line)
mediated by HCO4− stops the aggregation process at nano-scale level.
3. Discussion
Oxidative damage and amyloid accumulation are the key factors in the pathogenesis of AD.
The mechanism by which the amyloid peptide exerts its toxicity is still unknown, but an association
between Aβ toxicity and oxidative stress has been suggested and confirmed by several studies [34–36].
The Aβ fragment used in this work, the Aβ25-35, retains the toxic and aggregation properties
of the full-length peptide Aβ1-42 [6,25], which is the most abundant form in senile plaques. Indeed,
Aβ25-35 contains the Met-35 residue that, being the main target of oxidative reactions, is thought to be
responsible for the Aβ ability to generate free radicals and oxidative stress.
In this work we show that Aβ25-35 undergoes oxidative modifications by the action of oxidants
derived from the buffer HCO3−/CO2, i.e., PMC and carbonate radical anion. Indeed, a role of the main
physiological buffer in modulating biological oxidations is well established [37–39]. Even if both PMC
and carbonate radical anion derive from the same system, the reactions mediated by the two oxidants
proceed through different mechanisms: HCO4− is prevalently a two-electron oxidant, while CO3•− is
responsible for one-electron oxidations.
PMC can be generated through the equilibrium between bicarbonate and H2O2 and is capable of
oxidizing a variety of organic compounds. Owing to the fact that bicarbonate concentration in tissues
under physiological conditions is high (≥25 mM) and, for a fixed hydrogen peroxide concentration,
the rate of PMC formation is likely to be similar to that expected for hydroxyl radical formation from
redox-active iron(II) [40,41], HCO4− can be considered an reliable biological oxidant.
Our results indicate that PMC is able to oxidize thioether sulfur of Met-35 residue of Aβ25-35
to sulfoxide (MetSO). The Met oxidation to MetSO is well known and its presence in proteins is
an established marker of oxidative stress [18,42,43]. Mechanisms of oxidation of sulfides and free
methionine by PMC have been widely studied by Richardson and co-workers [44,45]. We observed that
PMC is more potent than hydrogen peroxide as concerns the Aβ oxidation, in accordance with some
experimental evidence on the ability of the bicarbonate/carbon dioxide system to promote oxidation,
peroxidation and nitration of several biological targets in the presence of hydrogen peroxide [37,46].
In these conditions, PMC is considered the chemical species responsible for the increment of oxidative
reactions. Although the formation of HCO4− from hydrogen peroxide and bicarbonate in aqueous
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solution at neutral pH is a relatively low process (k = 10−2 M−1sec−1), this value is influenced by
the presence of proteins and lipids [40], indicating that PMC can be physiologically generated from
hydrogen peroxide at high speed in biological tissues rich in proteins, lipids, and bicarbonate/CO2.
Interestingly, our experiments show that Aβ25-35 two-electron oxidation counteracts the tendency
of peptide to aggregate. This is in accordance with previous reports, indicating that the oxidation of
Met-35 also alters the physical properties of the peptide, such as aggregation tendency, leading to
a different oligomerization profile with significant attenuation of trimers and tetramers formation [47]
and reduction of fibril assembly [48]. Additionally, recent molecular dynamics simulation experiments
of Brown et al. [49] are consistent with a decrease in aggregation rate when Met-35 of Aβ1-40 is oxidized
to sulfoxide. Moreover, it has been observed that Met oxidation of Aβ generates very different fiber
morphologies compared to un-oxidized Aβ, with much shorter (<500 nm) fragmented fibers [50].
Noteworthily, also the inhibition of fibrillation of α-synuclein is mediated by methionine oxidation.
It has been suggested that α-synuclein completely oxidized to its Met residues shows a reduced
propensity to form amyloid fibrils, probably related to the interference of MetSO residues in oxidized
protein to form ordered β-type secondary structures [51].
The fact that oxidized amyloid possesses attenuated aggregating capacity validates the hypothesis
that oxidative stress in AD brain likely induces toxicity in a manner independent from fibril formation.
This theory is also supported, considering the outcomes of the one-electron oxidation of Aβ25-35 by
carbonate anion radical (CO3•−). This strong oxidant acts by both electron transfer and hydrogen
abstraction mechanisms to produce radicals from the oxidized targets [39] and is able to oxidize a broad
series of compounds of biochemical interest [52], including sulfur amino acids of proteins [53] in which
it adds to the sulfur atom, according to reactions [54]:
MetS + CO3−→MetS•CO3−
MetS•CO3−→MetS+ + CO32−
In our study CO3•− has been generated by SOD/H2O2/HCO3− system. Bicarbonate anion, owing
its small size, can easily reach SOD active site, where is oxidized to CO3•− by hydroxyl radical (•OH)
generated by the enzyme in the presence of hydrogen peroxide:
SOD-Cu(II) + H2O2→ SOD-Cu(I) + O2− + 2H+
SOD-Cu(I) + H2O2→ SOD-Cu(II)•OH + OH−
SOD-Cu(II)•OH + HCO3−→ SOD-Cu(II) + H2O + CO3−
To investigate the susceptibility of Aβ25-35 fragment to mono-electronic oxidation by carbonate
anion radical, we carried experiments using dihydrorhodamine-123 as a target of oxidative reaction by
CO3•−. We observed that the presence of Aβ25-35 determined a net decrease of DHR oxidation rate,
due to the fact that the peptide competes with DHR for the CO3•−. Instead, if Aβ25-35 is preventively
incubated for long times in favoring aggregation conditions, the DHR oxidation rate results also 1.3 fold
higher than that in absence of peptide. Therefore, the reactivity of amyloid with carbonate radical
anion confers to the peptide an antioxidant effect until it is in unaggregated form. On the contrary,
under conditions that favor the peptide aggregation, the antioxidant capacity is lost and the peptide
becomes pro-oxidant. This behavior suggests the formation of radical intermediates able to promote
the oxidative processes.
Compared to free methionine, Aβ25-35 was much more efficient as competitor of DHR for the
CO3•−-mediated oxidation (Figure 7). The low scavenger activity of free methionine is in accordance
with previous reports [52] on the greater susceptibility of amino acid residues into proteins respect to
free amino acids to be oxidized by carbonate anion radical. Additionally, our HPLC determinations
showed that, when free methionine was allowed to react in the presence of SOD/H2O2/HCO3−,
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it was only partially oxidized through one-electron transfer, and that a fraction was transformed in
sulfoxide through two-electron oxidation; on the contrary, CO3•− completely oxidized Aβ25-35, as
demonstrated by the fact that in the same conditions no peak attributable to two-electron oxidation of
Met residue appeared.
The pro-oxidant effect of Aβ has been often correlated to its ability to chelate metals, copper above
all, due to the presence of three histidine residues in the peptide chain [55,56] and it has been suggested
that this ability could explain the presence of elevated concentration of copper and other transition
metals in the senile plaques of AD subjects [57]. However, in our experiments, the pro-oxidant effect
has been observed despite the presence of DTPA, a strong metal-chelating agent, and even though the
truncated peptide we used, Aβ25-35, lacks of metal-binding residues of native peptide Aβ1-42. It can be
therefore hypothesized that the observed pro-oxidant activity could be linked to the high reactivity of
Met-35. Indeed, reactivity of methionine residues toward carbonate radical anion is in the order of
107 M−1sec−1, at least 100 fold greater than that of not-sulfur amino acids [52].
In the presence of CO3•−, methionine residue undergoes one-electron oxidation, generating
a sulfur radical cation. This “sulfur centered” radical is potentially pro-oxidant, since is able to remove
hydrogen atoms from protein and lipids, causing protein oxidation and lipid peroxidation [58]. At pH
7.4, the C-terminal of Aβ25-35, corresponding to methionine residue, is in the form of carboxylate anion.
The negatively charged oxygen could favor the oxidation of thioether sulfur and the stabilization of
the derived cation radical. Moreover, the MetS•+ radical cation in the full-length peptide Aβ1-42 can be
stabilized through bond formation with either the oxygen or the nitrogen atoms of adjacent peptide
bond [59]. Likely, this radical remains stabilized also during the aggregation process, therefore making
the peptide able to trigger oxidative reactions.
4. Materials and Methods
4.1. Reagents and Chemicals
Aβ25-35 fragment (NH2- and COOH-terminal free peptide), superoxide dismutase (SOD) from
bovine erythrocytes (EC 1.15.1.1), catalase, diethylenetriaminepentaacetic acid (DTPA), and Thioflavin-T
were obtained from Sigma (St. Louis, MO, USA). l-methionine and hydrogen peroxide (30%) were
purchased from Fluka (Buchs, Switzerland). All other chemicals were of the highest purity commercially
available. H2O2 concentration was verified using UV absorption at 240 nm (ε = 43.6 M−1cm−1) [60].
All solutions and buffers were prepared with distilled water purified in a Millipore (Burlington, MA,
USA) Milli-Q system and contained DTPA to avoid metal-dependent oxidative reactions.
4.2. Synthesis of PMC (HCO4−)
0.9 mL of 0.5 M sodium bicarbonate were added to 0.1 mL of 0.5 M hydrogen peroxide and the
solution was left to equilibrate at room temperature for 10 min. In these conditions, the concentration
of formed HCO4− calculated by the equation: [HCO4−] = 0.31 × [H2O2] [HCO3−], where 0.31 is the
value of k of equilibrium for the HCO4− formation [39], results to be 7.75 mM.
4.3. Two-Electron Oxidation of Aβ25-35 Fragment and L-Methionine by PMC
To reaction mixture containing 10 µM Aβ25-35 or 10 µM L-methionine in 0.1 M phosphate buffer,
pH 7.4, and 0.1 mM DTPA, PMC was added at 0.8 mM final concentration. After incubation at 37 ◦C for
various times, the reaction was stopped by addition of catalase (400 U/mL) and the reaction products
were analyzed by HPLC and mass spectrometry (Waters, Milford, MA, USA; Bruker Daltonics, Bremen,
Germany).
4.4. One-Electron Oxidation of Aβ25-35 Fragment and L-Methionine by SOD/H2O2 System
To reaction mixture containing 10 µM Aβ25-35 or 10 µM L-methionine in 0.1 M phosphate buffer,
pH 7.4, and 0.1 mM DTPA, SOD was added at 31 µM final concentration, in the presence or absence
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of 25 mM NaHCO3. The reaction was started by the addition of hydrogen peroxide at 1 mM final
concentration. After incubation at 37 ◦C for various times, the reaction was stopped by addition of
catalase (400 U/mL) and the reaction products were analyzed by HPLC.
4.5. HPLC Analysis
HPLC analysis of methionine and methionine sulfoxide (Met-SO), the two-electron oxidation
product, was performed with a Waters–Millipore Chromatograph (Milford, MA, USA) equipped
with a model 600 pump, a model 600 gradient controller, and a Waters 474 scanning fluorescence
detector (Milford, MA, USA). Samples were derivatized with o-phthalaldehyde-2-mercaptoethanol
(OPA) prior to injection [61] and applied on a Symmetry C18 column (5µ, 4.6 mm × 250 mm). Elution
was performed using as mobile phases: A) 50 mM sodium acetate buffer, pH 5.5-methanol (80:20, v/v)
B) 50 mM sodium acetate buffer, pH 5.5-methanol (20:80, v/v), flow rate 1mL/min, at room temperature.
The elution gradient was linear, from 100% A to 100% B in 30 min. The fluorescence of eluates was
monitored at 340 nm (λex) and 450 nm (λem). The retention time of L-methionine was 21 min and
concentrations were calculated from a standard curve.
For analysis of Aβ25-35 and its two-electron oxidation product, the UV Waters photodiode array
detector was used. The chromatography was carried out on a Nova-Pak C18 column (4 µ, 3.9 mm ×
150 mm). Elution was performed using as mobile phases: (A) 50 mM sodium phosphate buffer, pH
3.0-acetonitrile (90:10, v/v) (B) acetonitrile-water (50:50, v/v), flow rate 1mL/min, at room temperature
and with a linear gradient from 100% A to 100% B in 30 min. The absorbance of eluates was monitored
at 214 nm. The retention time of Aβ25-35 was 15 min and its concentration was calculated from
a standard curve using the Millenium 32 software (Waters). The same curve was used to determine
oxidized Aβ25-35 concentration, assuming the same absorbance at 214 nm for either Aβ25-35 and its
oxidized form.
4.6. Purification of the Product of Two-Electron Oxidation of Aβ25-35 Fragment by PMC
Then, 10. µM Aβ25-35 was allowed to react with PMC at 0.8 mM final concentration in 0.1 M
phosphate buffer, pH 7.4, containing 0.1 mM DTPA. After 120 min at room temperature, aliquots of
incubation mixture were loaded on Nova-Pak C18 column and subjected to HPLC in the conditions
previously described. The eluates, monitored at 214 nm, corresponding to the product of two-electron
oxidation of Aβ25-35, with a retention time of 11 min, were collected and analyzed by MALDI-ToF MS
spectrometry (Bruker Daltonics, Bremen, Germany) [62].
4.7. Mass Spectrometry
The peptide mixtures were loaded directly onto an appropriate MALDI target plate with 1 µL of
α-cyano-4-hydroxy-trans-cinnamic acid matrix solution (10 mg/mL) in 70% acetonitrile containing
0.1% TFA (v/v). MALDI-ToF MS analyses were performed by an AutoFlex II (Bruker Daltonics, Bremen,
Germany) equipped with a 337 nm nitrogen laser and operating in reflector mode. Mass data were
obtained by accumulating several spectra from laser shots with an accelerating voltage of 20 kV.
4.8. Effect of L-Methionine and Aβ25-35 Fragment on Dihydrorhodamine-123 (DHR)
Stock solution of 5 mM DHR in acetonitrile was prepared and stored in the dark at −20 ◦C.
Appropriate aliquots of L-methionine or Aβ25-35 (50 µM final concentration) were added to a solution
containing 25 µM DHR, 31 µM SOD, 0.1 mM DTPA, and 25 mM sodium bicarbonate in 0.2 M phosphate
buffer, pH 7.4. Reaction was started by the addition of 1 mM H2O2. Oxidized DHR was quantified
spectrophotometrically at 500 nm (ε = 78,000 M−1cm−1) [63] with a UV-Vis Perkin-Elmer (Waltham,
MA, USA).
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4.9. Thioflavin-T (ThT), Atomic Force Microscopy (AFM), and Dynamic Light Scattering Analyses (DLS)
One-electron oxidation, two-electron oxidation, and control Aβ25-35 (in PBS buffer) samples were
incubated for 24 h at room temperature. An aliquot of each sample was used for ThT, AFM, and DLS
experiments. Thioflavin T (ThT) binding assay was performed as reported [64]. Then, 50 µL of each
sample was added to a fresh 5 µM solution of Thioflavin-T (dissolved in 50 mM glycine solution,
pH 8.5) to rich a final 10 µM Aβ25-35 concentration. Fuorescence was measured on a SPEX-Fluoromax
spectrofluorometer (Horiba Scientific, Horiba Ltd., Kyoto, Japan) with λex = 440 nm and λem = 485 nm.
The results are presented as mean and S.D. of three separate measurements.
The samples for the AFM characterization were prepared by the casting method, by manually
dropping 5 µL of sample solution onto freshly cleaved mica and then air dried overnight, as previously
described [33]. The AFM images were acquired using a home-designed microscope, described in
detail elsewhere [65], operating in contact mode, in air, at room temperature and constant 30% relative
humidity. The AFM tips chosen were made of silicon nitride (Veeco, New York, NY, USA) with tip of
asymmetric pyramidal shape and nominal radius on 10 nm. During the imaging the vertical force was
maintained below 1 nN in order to not damage the samples. The acquired images (8 × 8 micron, 600 ×
600 points) were then treated using the freeware software Gwyddion (www.gwyddion.net).
For DLS experiments each samples was filtered onto 0.45 µm filters to retain insoluble and over
micron scale aggregates and analyzed after one hour from filtration. The DLS measurements were taken
using a HORIBA LB-550 instrument at a 650 nm Laser diode wavelength (5 mW), with a temperature
control capacity set at 25 ◦C. To ensure accurate readings, the final distribution was taken from an
accumulation of 100 individual DLS collections of three individual aliquots for each sample.
4.10. Statistics
Results are expressed as means ± SEM for at least three separate experiments performed in
duplicate. Graphics and data analysis were performed using GraphPad Prism 4 software.
5. Conclusions
Although the origin of oxidative damage in AD is not yet fully understood, our experiments
confirm that amyloid peptide is liable to be oxidized at level of methionine residue and that the effects
of such oxidation vary depending whether one- or two-electron mechanisms are implied. While
bi-electronic oxidation of the thioether sulfur of Met-35 to sulfoxide determines an attenuation of
aggregation capacity of the peptide, as demonstrated by our and other authors’ experiments [19],
the one-electron oxidation leads to the formation of sulfur radical cation (MetS•+). The latter, like
other radicals with sulfur in high oxidation states that can be originated in vivo in oxidative stress
conditions [66], has oxidizing properties similar to ROS and is able to trigger and spread oxidative
reactions. Therefore, though the sulfur-containing biomolecules have antioxidant activity, the transient
formation of these reactive species during redox reactions may have a patho-physiological relevance [67].
This is a further confirmation of the model of free radical-based neurotoxicity of Aβ in AD, supported
by numerous lines of evidence [16,24], according which the peptide initiates free radical processes
resulting in protein oxidation, lipid peroxidation, reactive oxygen species formation, and cellular
dysfunctions leading to neuronal death [16].
Finally, it is noteworthy that the oxidative agents used in this work, i.e., PMC and carbonate radical
anion, derive in vivo from the main physiological buffer, the bicarbonate/CO2 pair, which can promote
either mono-electronic oxidations mediated by peroxynitrite, SOD, xanthine oxidase, or bi-electronic
oxidations mediated by hydrogen peroxide. The high bicarbonate concentration physiologically
present in tissues makes the importance of the two species very considerable. The described processes
may occur in physiological conditions, and the inclusion of these species within the more prominent
biological oxidants can give new prompts in the comprehension and control of the mechanisms of
many pathologies.
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It should be emphasized that free radicals and oxidants are currently considered as important
mediators in the response of various signaling molecules and pathways involved in physiologic and
pathologic processes. A better understanding of cellular oxidative mechanisms, many of which are
likely to be modulated by the ubiquitous bicarbonate/carbon dioxide pair, can be very helpful for the
elucidation of these interrelated processes.
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